Oncology Flashcards
A 72-year-old lady presents with a complaint of a unilateral mass in the right upper quadrant of the breast, which is hard in consistency and associated with enlarged axillary lymph nodes, which are fixed.
Carcinoma
Breast cancer is around a hundred times more common in women than men. Its incidence increases with age. The main features include a painless, firm to hard mass, with irregular borders fixed to adjacent tissues, nipple retraction and discharge, breast asymmetry and skin changes. Features of advanced disease include bone pain weight loss and arm swelling. Definite diagnosis is by biopsy.
A 21-year-old lady attends with a firm mass in the upper quadrant of the left breast. This mass is mobile, no axillary nodes are palpable.
Fibroadenoma
Fibroadenomas are the most common benign female breast tumours. They occur most often during the reproductive years. They usually have a rubbery feel on palpation and are mobile. They are not tender and do not become malignant. The diagnosis is confirmed by biopsy.
A 32-year-old woman complains of lumps and discomfort in her left breast. Her symptoms are intermittent and peak just before her periods.
Fibrocystic disease
Fibrocystic changes can occur in either or both breasts, and are most common in the upper, outer quadrants. These changes are benign and do not increase the risk of breast cancer. Symptoms, especially discomfort, are related to, and peak before, the menstrual periods. The breast tissue has a cobblestone feel on palpation.
A 58-year-old woman attends with excoriation of the skin of her right nipple and has been aware of a bloody discharge.
Intraduct carcinoma in situ
Intraductal carcinoma in situ and carcinoma may present primarily with bloody, painless, nipple discharge. The nipple may be deformed or retracted and itchy - Paget’s disease. In the absence of a mass, 70% have carcinoma in situ and 30% invasive carcinoma.
A 24-year-old woman, who has been breast feeding her infant, develops a painful swelling in her left breast. She is pyrexial and has a erythematous, tender and swollen left breast with a vague mass underlying the nipple.
Breast abscess
Breast abscesses are common in lactating women, and are associated with all the features of inflammation as demonstrated in this case - redness, pain, heat and tenderness.
A 70-year-old male receiving treatment for metastatic bronchial carcinoma complains of deteriorating dyspnoea. He is noted to have compromised respiratory function.
Start oxygen therapy
The patient with bronchial carcinoma and dyspnoea would most appropriately be treated with oxygen.
A 72-year-old male diagnosed with metastatic bowel carcinoma is being treated for bone pain with high doses of oral morphine sulphate. Recently he has become aware of increasing constipation and lower abdominal pain.
Macrogol
The patient with metastatic bowel carcinoma has typical opioid side effects of constipation. The most appropriate treatment is macrogol in the first instance.
A 75-year-old patient treated with tramadol for control of pain related to metastatic malignant melanoma. The patient still feels that the pain is unbearable.
Escalate opioid therapy
The patient with the metastatic malignant melanoma has pain despite tramadol. Consequently escalation of opioid analgesia is required with the introduction of oramorph as the next appropriate step.
A 66-year-old female with carcinoma of the breast associated with multiple metastases is receiving palliative care. She develops severe nausea and vomiting and bone pains. Investigations reveal a serum calcium concentration of 3.5 mmol/l.
Pamidronate IV
The patient with breast carcinoma has symptoms of symptomatic hypercalcaemia and the most appropriate therapy is IV rehydration and pamidronate therapy. Pamidronate, a bisphosphonate may also be associated with the relief of bone pain.
An 80-year-old male receiving treatment for prostate carcinoma complains of pelvic pain and is noted to have pelvic metastases on radiological investigation.
Palliative radiotherapy
The patient with prostate carcinoma may well respond to palliative radiotherapy which should be considered in this case.
A 65-year-old female is receiving treatment for colon cancer with a combination chemotherapy regime that includes irinotecan. Which of the following best describes the action of irinotecan? (Please select 1 option) Alkylating agent DNA antimetabolites Inhibition of protein synthesis RNA/DNA antimetabolites Topoisomerase inhibitor
Topoisomerase inhibitor This is the correct answerThis is the correct answer
Irinotecan is a chemotherapy agent that is a topoisomerase 1 inhibitor. Chemically, it is a semisynthetic analogue of the natural alkaloid Camptothecin.
Its main use is in colon cancer, particularly in combination with other chemotherapy agents. This includes the regimen FOLFIRI which consists of infusional 5-fluorouracil, leucovorin, and irinotecan.
A 69-year-old gentleman presents with loin pain and frank haematuria.
After investigation he is diagnosed with a renal cell carcinoma.
Which is the most common mode of initial dissemination of renal cell carcinoma?
(Please select 1 option)
Along the renal vein
Multiple lung metastases that regress after resection of the primary
Solitary lung metastases
To the IVC
To the ureter
Along the renal vein
Renal cell carcinomas are prone to spread into the renal vein from where they can grow into the IVC.
Tumour thrombi may also be swept into the circulation where they lodge in the lungs as cannon ball metastases.
A 31-year-old male is receiving treatment for testicular carcinoma with cisplatin based chemotherapy. Which of the following best describes the action of cisplatin? (Please select 1 option) Alkylating agent DNA antimetabolites Inhibition of protein synthesis RNA/DNA antimetabolites Topoisomerase inhibitor
Alkylating agent
Cisplatin is a platinum based chemotherapy used in the treatment of testicular tumours, ovarian tumours and lymphomas. It functions through crosslinking DNA preventing the division required for rapid mitosis. Although it does not have an alkyl group, it is classed as an alkylating agent.
A 30-year-old woman has a right mastectomy and axillary lymph node dissection for a carcinoma diagnosed by fine needle aspiration cytology.
The histological pattern is that of a poorly differentiated carcinoma that is negative for oestrogen and progesterone receptors, but is positive for HER2/neu. One axillary lymph node demonstrates micro-metastases.
Her 32-year-old sister is found to have a similar lesion.
Which of the following statements regarding risk factors for this lesion is the most appropriate?
(Please select 1 option)
A history of late menarche is likely to be present in females in this family
Fibrocystic changes were present for many years
She had a history of exposure to hydrocarbon compounds
She has a positive antinuclear antibody test
These findings suggest a BRCA-1 mutation
These findings suggest a BRCA-1 mutation This is the correct answerThis is the correct answer
A small number of breast cancers are the result of an inherited BRCA-1 mutation (or BRCA-2) but the family history of breast cancer at a young age makes this more likely.
Early menarche and late menopause and nulliparity are risks for breast cancer.
Autoimmune diseases do not appreciably increase the risk for breast cancer.
A 24 year man with 47XXY karyotype is found to have an anterior mediastinal mass which on histology shows a germ cell tumour
AFP
Klinefelter syndrome is associated with the development of non-seminomatous germ cell tumours. Non seminomatous germ cell tumours are associated with elevated AFP or beta subunit Human chorionic gonadotrophin.
A 45-year-old woman attends follow up; she previously had a total thyroidectomy and radioiodine therapy as management of her papillary thyroid cancer.
Serum thyroglobulin
Well differentiated thyroid cancer comprises 1% of all malignancies. It is the most common endocrine malignancy. Serum thyroglobulin is an important monitoring tool, useful in detecting relapse of well differentiated thyroid cancer, following complete removal of thyroid tissue surgically and radioiodine ablation.